Filing Details
- Accession Number:
- 0001127602-20-021918
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-21 20:43:39
- Reporting Period:
- 2020-07-20
- Accepted Time:
- 2020-07-21 20:43:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1690927 | Zvi Tal Zaks | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-07-20 | 10,000 | $20.93 | 10,000 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-07-20 | 10,000 | $19.15 | 20,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-07-20 | 400 | $78.77 | 19,600 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-20 | 1,650 | $80.49 | 17,950 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-20 | 2,205 | $81.23 | 15,745 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-20 | 4,488 | $82.49 | 11,257 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-20 | 3,425 | $83.17 | 7,832 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-20 | 2,409 | $84.53 | 5,423 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-20 | 3,469 | $85.58 | 1,954 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-20 | 1,000 | $86.37 | 954 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-20 | 354 | $87.41 | 600 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-20 | 400 | $88.76 | 200 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-20 | 200 | $90.64 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-20 | 10,000 | $0.00 | 10,000 | $20.93 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-07-20 | 10,000 | $0.00 | 10,000 | $19.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
309,195 | 2020-03-08 | 2029-03-08 | No | 4 | M | Direct |
214,790 | 2026-08-10 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.41 to $79.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.77 to $80.76 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.80 to $81.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.81 to $82.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.82 to $83.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.96 to $84.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.97 to $85.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.98 to $86.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.05 to $87.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.59 to $88.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- This option is fully vested and exercisable.
- This option is fully vested and exercisable.